elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26771638-ED198EB3-0FFB-446F-84CD-E9F86251C580
Q26771638-ED198EB3-0FFB-446F-84CD-E9F86251C580
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26771638-ED198EB3-0FFB-446F-84CD-E9F86251C580
Drug discovery in ophthalmology: past success, present challenges, and future opportunities
P2860
Q26771638-ED198EB3-0FFB-446F-84CD-E9F86251C580
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26771638-ED198EB3-0FFB-446F-84CD-E9F86251C580
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b5e132f0d3ebc719de9383fb46a1618cbd09cf96
P2860
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer